SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001214659-19-005883
Filing Date
2019-09-16
Accepted
2019-09-16 16:22:39
Documents
1
Group Members
DENNISON T. VERUPALISADE CAPITAL ADVISORS, LLCPALISADE CAPITAL MANAGEMENT, L.L.C.

Document Format Files

Seq Description Document Type Size
1 d911190sc13d.htm SC 13D 99626
  Complete submission text file 0001214659-19-005883.txt   101393
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42755 | Film No.: 191094941
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE BRIDGE PLAZA SUITE 695 FORT LEE NJ 07024
Business Address ONE BRIDGE PLAZA SUITE 695 FORT LEE NJ 07024 201-585-7733
Palisade Concentrated Equity Partnership II, LP (Filed by) CIK: 0001291027 (see all company filings)

IRS No.: 861103899 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D